Case Report
This article is a minireview on the evolutionary course of non-small-cell lung cancer treatment over recent years, and discusses a case involving a patient who tested negative for PD-L1 but experienced a sustained complete response to explore strategies for addressing this specific tumour context.
Commentary
In this Commentary, the role of diet in cancer is discussed following the scientific evidence suggesting that excessive consumption of red meat and processed foods is correlated with a greater risk of contracting cancer.
Original Research
This study aims to determine the percentage of patients whose initial luteinizing hormone-releasing hormone agonists prescription was renewed during follow-up, how many changed formulation and how their quality of life evolved.
Corrigendum
The authors wish to make the following corrections to their article: Rossini B, Cecchi N, Clemente F, De Paolis MR, Hohaus S, Innao V, Lucignano M, Massaiu R, Palumbo G, Rigolin GM, Rossi FG, Verga L, Guarini A. Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences. Drugs Context. 2024;13:2023-9-4. https://doi.org/10.7573/dic.2023-9-4
Review
This article aims to review the literature on mechanisms of post-contrast acute kidney injury, risk factors and available strategies to control the risk in patients with cancer and to report the authors’ experience with managing post-contrast acute kidney injury risk in oncology.
